XENON PHARMACEUTICALS INC
Action · CA98420N1050 · XENE · A12ETN (XNMS)
31,64 USD
06.06.2025 20:00
Cours actuels de XENON PHARMACEUTICALS INC
Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière |
---|---|---|---|---|---|
![]() NASDAQ |
XENE
|
USD
|
06.06.2025 20:00
|
31,64 USD
| 30,73 USD
+2,96 %
|
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
0,00 % | 9,67 % | -10,06 % | -15,20 % | -25,94 % | -16,36 % | 167,46 % |
Profil de l'entreprise pour XENON PHARMACEUTICALS INC Action
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other potential indications, including adult focal epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop PCRX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Fonds investis
Les fonds suivants ont investi dans : XENON PHARMACEUTICALS INC investi :
Fonds | Vol. en millions 25,16 | Part (%) 0,06 % |
Données de l'entreprise
Nom XENON PHARMACEUTICALS INC
Société Xenon Pharmaceuticals Inc.
Symbole XENE
Site web
https://www.xenon-pharma.com
Marché d'origine
NASDAQ/NMS (GLOBAL MARKET)
WKN A12ETN
ISIN CA98420N1050
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Ian C. Mortimer C.M.A., CPA, M.B.A.
Capitalisation boursière 3 Mrd.
Pays Canada
Devise USD
Employés 0,3 T
Adresse 3650 Gilmore Way, V5G 4W8 Burnaby
Date d'introduction en bourse 2014-11-05
Symboles boursiers
Nom | Symbole |
---|---|
Frankfurt | XP0.F |
NASDAQ | XENE |
Autres actions
Les investisseurs qui détiennent XENON PHARMACEUTICALS INC ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.